Roh, Tae Hoon http://orcid.org/0000-0002-1004-9364
Lee, Ji-Hyun
Kim, Seo Jin
Shim, Jin-Kyoung
Park, Junseong http://orcid.org/0000-0003-0436-8614
Yoon, Seon-Jin http://orcid.org/0000-0002-3255-5081
Teo, Wan-Yee
Kim, Se Hoon http://orcid.org/0000-0001-7516-7372
Chang, Jong Hee http://orcid.org/0000-0003-1509-9800
Kang, Seok-Gu http://orcid.org/0000-0001-5676-2037
Funding for this research was provided by:
National Research Foundation of Korea (NRF-2019R1A2C3004155, 2020M3E5E2037960, 2020M2D9A2092372, 2020M3A9E8024890)
Yonsei University College of Medicine (6-2021-0006)
Article History
Received: 29 September 2021
Accepted: 16 November 2021
First Online: 22 November 2021
Declarations
:
: Seok-Gu Kang is a scientific advisor for ImmunoMet Therapeutics. The other authors declare no conflict of interest.
: All applicable international, national, and/or institutional guidelines for the care and use of animals were followed. All procedures performed in studies involving animals followed the ethical standards of the institution or practice at which the studies were conducted.
: Not applicable.